Turning patients may improve breathing in the ICU, new study suggests
NCT ID NCT07323472
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at how changing body position with an automatic bed affects breathing effort and lung function in 30 critically ill adults on ventilators. Researchers will measure muscle activity and lung images to see which positions help patients breathe better. The goal is to find safer ways to care for ICU patients without any direct treatment or cure.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 30 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Jan 2026
- Expected to finish
-
Dec 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Patients of both sexes will be included; * Aged ≥ 18 years; * BMI 18-35 kg/m²; * Under invasive mechanical ventilation via orotracheal tube for ≥ 24 hours and expected to remain on mechanical ventilatory support for at least 48 hours; * Sedated (Richmond Agitation-Sedation Scale \[RASS\] -1 to -4); * Well adapted to protective ventilation strategies in VCV or PSV modes; * Presenting neural respiratory drive evidenced by a drop in Delta Pocc and/or the presence of assisted cycles; * Hemodynamically stable (mean arterial pressure between 60-120 mmHg, systolic arterial pressure between 90-180 mmHg, diastolic arterial pressure between 60-100 mmHg, and heart rate between 50-150 bpm) with or without vasoactive drugs at the time of data collection (\> 0.1 to 0.3 mcg/kg/min); * Respiratory stability, no use of accessory muscles and target SpO₂ achieved; * No indication for nebulization or heated humidification at the time of collection; * Positive tolerance test for lateral decubitus positioning; * Chest circumference of 78-87.9 cm (XS), 88-99.9 cm (S), or 100-111.9 cm (M). Exclusion Criteria: * Patients presenting medical restrictions to body repositioning, or to the use of EIT or sEMG; * Those in therapeutic failure; * Individuals with spinal cord injury, brain injury, or stroke with a history of functional loss and respiratory impairment prior to hospitalization; * Neurological diseases affecting respiratory myoelectric conduction; * History of postural deformities, diaphragmatic abnormalities, or colostomy bag; * Unstable fracture (lower or upper limbs in proximal regions or thorax); * Pleural effusion requiring drainage; * Presence of drains in the thoracic and/or abdominal regions; * Unstable intracranial pressure; * Pregnant patients; * Immediate postoperative period of orthopedic surgeries; * Use of mucolytics; * Open ventriculostomy for drainage; * Uncontrolled agitation; * Pacemaker or implantable cardioverter-defibrillator; * Pneumothorax; * Use of neuromuscular blockers; * Active tuberculosis; * Traction devices; * Active bleeding; * Suspected or confirmed pulmonary embolism without prior treatment within 24 hours; * Presence of a large mass in the right and/or left hemithorax; * History of cardiopulmonary arrest within the past 24 hours under neuroprotection; * In the total weaning phase from IMV and/or tracheostomy and/or enteral feeding tube and/or scheduled CT scan within the next 6 hours; * Intolerance to the TLA test (SpO₂ drop \<92% or ≥20% from baseline, need for FiO₂ increase \>50% or ≥20% from baseline, need for PEEP increase, or hemodynamic instability within the first 5 minutes of lateralization testing); * Those who refuse to provide consent, as determined by the legal representative.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Intensive care units (ICUS) are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Hospital Geral Otávio de Freitas - Secretaria de Saúde de Pernambuco
RECRUITINGRecife, Pernamu, 50670-901, Brazil
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can ICU teams predict which hemofiltration patients will develop pressure wounds?
- Can tailored breathing support and early muscle relaxants boost survival in ARDS?
- New nursing strategy aims to cut ICU infections
- Heart scans reveal best breathing test for ICU patients
- Global ICU rehab study aims to boost recovery for ventilator patients
- New vital sign tracker tested for surgery patients at home